Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)

New Taipei City

Kaohsiung City

Budapest

Bruxelles - Brussel

Sofia

Vienna

Sofia

Sofia

Sofia

Darlinghurst

Mol

Mechelen

Sankt Pölten

Prahran

Linz

Bruderholz

Liestal

Huy

Salzburg

Stara Zagora

Gilly

Lugano

Hobart

Bruges

Székesfehérvár

Graz

Zurich

Aarhus N

Roeselare

Viborg

Ghent

Aalborg

Taipei

Prague

Taipei

Athens

Prague

Buffalo

Nea Ionia

Greifswald

Wilmington

Milan

Milan

Milan

Hamburg

Como

Bergamo

Brescia

Pavia

Majadahonda

Charleston

Atlanta

Hanover

Macon

Jacksonville

Fort Lauderdale

Pessac

Naples

Verona

Germantown

La Tronche

Santander

Columbus

Fairfield

Valencia

Valencia

Münster

Detroit

Cologne

Arezzo

Milwaukee

Minneapolis

Lille

Ancona

Frankfurt am Main

Bad Homburg

Homburg

Bron

Paris

Rouen

München

Fountain Valley

Erfurt

Singapore

Singapore

Singapore

Singapore

Tiberias

Afula

Hadera

Petah Tikva

Tel Aviv

Zrifin

Rehovot

Ashkelon

Jerusalem

New Orleans

Jackson

Nashville

Toronto

Montreal

Montreal

Saint-Jean-sur-Richelieu

Sherbrooke

Québec

Hradec Králové

Kroměříž

Fakultni nemocnice Ostrava, Ostrava

Prague

Prague

Slaný

Hellerup

Kistarcsa

Iizuka

Himeji

Kanazawa

Sagamihara

Yokohama

Yokosuka

Sendai

Naha

Takatsuki

Yao

Ureshino

Komatsushimachō

Meguro-ku

Minato-ku

Fukui

Hiroshima

Kumamoto

Nagasaki

Tokushima

Toyama

Amsterdam

Deventer

Heerenveen

Leeuwarden

Veldhoven

Bialystok

Krakow

Legnica

Lodz

Olsztyn

Poznan

Warsaw

Seoul

L'Hospitalet de Llobregat

Barcelona

Barcelona

Helsingborg

Karlstad

Linköping

Malmo

Örebro

Stockholm

Chesterfield

Stevenage